Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Dale

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
Blood|August 1, 1990
A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSFW P Hammond, T C Boone, R E Donahue, et al.
The New England Journal of Medicine|May 8, 1980
The cost effectiveness of therapeutic and prophylactic leukocyte transfusionM S Rosenshein, V T Farewell, T H Price, et al.
Blood|January 1, 1995
Long-term treatment of canine cyclic hematopoiesis with recombinant canine stem cell factorD C Dale, E Rodger, J Cebon, et al.
The American Journal of Medicine|May 1, 1981
Restructuring an internal medicine residency program to meet regional and national needs for general internistsD C Dale, J F Wallace, H Clark, et al.
The Journal of Infectious Diseases|March 9, 1999
Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogensJ M Gaviria, J A van Burik, D C Dale, et al.
The Journal of Infectious Diseases|April 7, 1999
Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivoJ M Gaviria, J A van Burik, D C Dale, et al.
Journal of Gerontology|September 1, 1993
Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3G S Chatta, R G Andrews, E Rodger, et al.
The Journal of Infectious Diseases|April 1, 1997
Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogensW C Liles, J E Huang, J A van Burik, et al.
Transfusion|February 1, 1997
A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteersW C Liles, J E Huang, C Llewellyn, et al.
International Journal of Antimicrobial Agents|May 1, 1997
Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpointJ J Rusthoven, E G de Vries, D C Dale, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Blood|August 1, 1990
A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSFW P Hammond, T C Boone, R E Donahue, et al.
The New England Journal of Medicine|May 8, 1980
The cost effectiveness of therapeutic and prophylactic leukocyte transfusionM S Rosenshein, V T Farewell, T H Price, et al.
Blood|January 1, 1995
Long-term treatment of canine cyclic hematopoiesis with recombinant canine stem cell factorD C Dale, E Rodger, J Cebon, et al.
The American Journal of Medicine|May 1, 1981
Restructuring an internal medicine residency program to meet regional and national needs for general internistsD C Dale, J F Wallace, H Clark, et al.
The Journal of Infectious Diseases|March 9, 1999
Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogensJ M Gaviria, J A van Burik, D C Dale, et al.
The Journal of Infectious Diseases|April 7, 1999
Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivoJ M Gaviria, J A van Burik, D C Dale, et al.
Journal of Gerontology|September 1, 1993
Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3G S Chatta, R G Andrews, E Rodger, et al.
The Journal of Infectious Diseases|April 1, 1997
Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogensW C Liles, J E Huang, J A van Burik, et al.
Transfusion|February 1, 1997
A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteersW C Liles, J E Huang, C Llewellyn, et al.
International Journal of Antimicrobial Agents|May 1, 1997
Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpointJ J Rusthoven, E G de Vries, D C Dale, et al.
Pageof 17